R. Mechoulam
Pharmacology · 2000–2013
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 43 citations into it; #396 of 1,112 by trust here, #92 by citations
- Cellular and Molecular Neuroscience — 30 citations into it; #2,285 of 2,998 by trust here, #873 by citations
Whom R. Mechoulam trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Mechoulam overall
Papers from R. Mechoulam's perspective
Ordered by how strongly the researchers R. Mechoulam trusts endorse each paper. Same corpus, a different order for every researcher.
- Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. (Neuron)
- Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide (British Journal of Pharmacology)
- Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α (Nature)
- Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses (Nature)
- Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 (Nature)
- Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. (Brain Research)
- Pharmacological actions of cannabinoids. (Handbook of Experimental Pharmacology)
- Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. (Journal of Clinical Endocrinology and Metabolism)
- Cannabinoid receptors and their ligands. (Prostaglandins, Leukotrienes and Essential Fatty Acids)
- 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- The endocannabinoid system and the brain. (2013) — 1,009 citations
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (2010) — 1,739 citations
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. (2009) — 791 citations
- International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors (2002) — 2,760 citations
- Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide (2001) — 1,164 citations
- 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (2001) — 788 citations
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injury (2001) — 747 citations
- The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. (2000) — 636 citations